TY - JOUR
T1 - Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence
T2 - A systematic review
AU - Ross, Sue
AU - Soroka, Dana
AU - Karahalios, Amalia
AU - Glazener, Cathryn M A
AU - Hay-Smith, E. Jean C
AU - Drutz, Harold P.
PY - 2006
Y1 - 2006
N2 - This systematic review examined the use of incontinence-specific quality of life (QOL) measures in clinical trials of female incontinence treatments, and systematically evaluated their quality using a standard checklist. Of 61 trials included in the review, 58 (95.1%) used an incontinence-specific QOL measure. The most commonly used were IIQ (19 papers), I-QoL (12 papers) and UDI (9 papers). Eleven papers (18.0%) used measures which were not referenced or were developed specifically for the study. The eight QOL measures identified had good clinical face validity and measurement properties. We advise researchers to evaluate carefully the needs of their specific study, and select the QOL measure that is most appropriate in terms of validity, utility and relevance, and discourage the development of new measures. Until better evidence is available on the validity and comparability of measures, we recommend that researchers consider using IIQ or I-QOL with or without UDI in trials of incontinence treatments.
AB - This systematic review examined the use of incontinence-specific quality of life (QOL) measures in clinical trials of female incontinence treatments, and systematically evaluated their quality using a standard checklist. Of 61 trials included in the review, 58 (95.1%) used an incontinence-specific QOL measure. The most commonly used were IIQ (19 papers), I-QoL (12 papers) and UDI (9 papers). Eleven papers (18.0%) used measures which were not referenced or were developed specifically for the study. The eight QOL measures identified had good clinical face validity and measurement properties. We advise researchers to evaluate carefully the needs of their specific study, and select the QOL measure that is most appropriate in terms of validity, utility and relevance, and discourage the development of new measures. Until better evidence is available on the validity and comparability of measures, we recommend that researchers consider using IIQ or I-QOL with or without UDI in trials of incontinence treatments.
KW - Clinical face validity
KW - Incontinence-specific quality of life measures
KW - Outcome measurement
KW - Psychometric properties
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=33645468742&partnerID=8YFLogxK
U2 - 10.1109/TAP.2005.861506
DO - 10.1109/TAP.2005.861506
M3 - Article
C2 - 16025188
AN - SCOPUS:33645468742
SN - 0937-3462
VL - 17
SP - 272
EP - 285
JO - International Urogynecology Journal
JF - International Urogynecology Journal
IS - 3
ER -